Tillis, Senate Republicans Blast Innovation-Stifling Drug-Pricing Model
March 11, 2023
March 11, 2023
WASHINGTON, March 11 -- Sen. Thom Tillis, R-North Carolina, issued the following news release and letter:
This week, U.S. Senator Thom Tillis (R-NC), a member of the Senate Finance Committee, and Senate Republicans pushed back against government health officials on the implementation of a drug-pricing model selected by the Department of Health and Human Services (HHS) to complement the Administration's prescription drug pricing scheme.
In a letter to HHS Secretary . . .
This week, U.S. Senator Thom Tillis (R-NC), a member of the Senate Finance Committee, and Senate Republicans pushed back against government health officials on the implementation of a drug-pricing model selected by the Department of Health and Human Services (HHS) to complement the Administration's prescription drug pricing scheme.
In a letter to HHS Secretary . . .